Cromos Pharma, where the patients are

Drug Sponsors

FutuRx begins operations in Israel

Monday, January 13, 2014 11:45 AM

FutuRx Incubator, formerly BioBoost, which has been granted a license by Israel's Ministry of Economy to establish a biotech incubator in Israel, began operations Jan. 1 at the Weizmann Science Park in Ness Ziona. Thirty to 40 startup companies are planned to be established during the next eight years. FutuRx was incorporated jointly by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development (JJDC) and Takeda Pharmaceutical through its corporate venture arm Takeda Ventures.

More... »

CRF Health eCOA webinar series

Lexicon reorganizes, cuts 115 R&D jobs

Monday, January 13, 2014 11:44 AM

Lexicon Pharmaceuticals is narrowing its strategic focus, directing its resources on its late-stage drug development programs, principally LX4211 for diabetes and telotristat etiprate (LX1032) for carcinoid syndrome, and preparation for the transition to commercialization.

More... »


GE acquires assets from Thermo Fisher Scientific

Monday, January 6, 2014 03:06 PM

GE Healthcare will acquire Waltham, Mass.-based Thermo Fisher Scientific’s HyClone cell culture (sera and media), gene modulation and magnetic beads businesses for approximately $1.06 billion.

More... »

Sanofi to expand access to clinical trial data

Friday, January 3, 2014 02:43 PM

Starting this month, Sanofi will expand access to information and data from clinical trials sponsored by companies of the Sanofi group, in support of industry-wide efforts to promote a set of Principles for Responsible Sharing of Clinical Trial Data that the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) jointly released in July 2013 and put into effect Jan. 1.

More... »

Arsenal Capital Partners acquires Certara

Friday, December 20, 2013 01:47 PM

Arsenal Capital Partners, a New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, has acquired Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical R&D market.

More... »

Jazz Pharmaceuticals to acquire Gentium

Friday, December 20, 2013 01:45 PM

Jazz Pharmaceuticals, a specialty biopharmaceutical company focused on unmet medical needs, has agreed to acquire biopharmaceutical Gentium for a cash tender offer of $57 per share for all outstanding Gentium ordinary shares and American Depositary Shares, in a transaction valued at approximately $1 billion.

More... »

Intrexon to acquire Medistem

Friday, December 20, 2013 01:44 PM

Intrexon, a company focused on synthetic biology, will acquire San Diego-based Medistem for approximately $26 million.

More... »

Bayer to acquire Algeta

Friday, December 20, 2013 01:41 PM

Bayer, through Aviator Acquisition, a wholly-owned subsidiary of Bayer Nordic, will launch a voluntary offer to acquire Algeta for $58.7 per share in cash, for a total value of approximately $2.9 billion. Algeta’s board of directors has unanimously decided to recommend its shareholders accept the offer.

More... »

AstraZeneca to acquire Bristol-Myers Squibb share of diabetes alliance assets

Friday, December 20, 2013 11:00 AM

AstraZeneca will acquire the entirety of Bristol-Myers Squibb's interest in the companies' diabetes alliance for $2.7 billion, and up to $1.4 billion in regulatory, launch and sales-related payments. AstraZeneca also has agreed to pay various sales-related royalty payments up until 2025 and may make payments up to $225 million when certain assets are subsequently transferred.

More... »

Endo to acquire NuPathe

Wednesday, December 18, 2013 01:44 PM

Endo Health Solutions, a U.S.-based specialty healthcare company, has entered into a definitive agreement to acquire NuPathe, a specialty pharmaceutical company focused on neuroscience solutions for central nervous system diseases, for $2.85 per share in cash, or approximately $105 million. 

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs